Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Lead negatively impacts cognitive functions of boys more than girls

  • Brain Secrets Unlocked by International Imaging Effort

  • Estrogen-producing neurons influence aggression in both sexes

  • Sleeping on stomach may increase risk of sudden death in epilepsy

  • On the ups and downs of the seemingly idle brain

  • Hunger hormone in infancy may link to lifelong obesity risk

  • Why all-nighters don't work: How sleep, memory go hand-in-hand

  • The brain's electrical alphabet: Timing, rate underlie neural information, study shows

  • New brain pathway offers hope for treating hypogylcemia

  • New 'systems genetics' study identifies possible target for epilepsy treatment

  •